NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor
Clinical trial NCT06134960 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06134960
- Sponsor
- Peking University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-16
- Primary completion
- 2026-06-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.